Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 625.00 | 414.82 | 387.00 | 799.25 | 0.4842 | -0.0707 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 625.00 | 414.82 | 931.00 | 799.25 | 1.1648 | 1.3500 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 625.00 | 414.82 | 287.00 | 799.25 | 0.3591 | -0.3225 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 895.00 | 799.25 | 1.1198 | 1.2541 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 634.00 | 799.25 | 0.7932 | 0.5657 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 414.82 | 769.00 | 799.25 | 0.9622 | 0.9201 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 840.00 | 799.25 | 1.0510 | 1.1079 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 630.00 | 799.25 | 0.7882 | 0.5553 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 625.00 | 414.82 | 867.00 | 799.25 | 1.0848 | 1.1796 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 522.00 | 799.25 | 0.6531 | 0.2750 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 414.82 | 306.00 | 799.25 | 0.3829 | -0.2750 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 607.00 | 799.25 | 0.7595 | 0.4953 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 625.00 | 414.82 | 918.00 | 799.25 | 1.1486 | 1.3153 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 802.00 | 799.25 | 1.0034 | 1.0073 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 625.00 | 414.82 | 755.00 | 799.25 | 0.9446 | 0.8832 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 414.82 | 372.00 | 799.25 | 0.4654 | -0.1088 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 625.00 | 414.82 | 440.00 | 799.25 | 0.5505 | 0.0643 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 963.00 | 799.25 | 1.2049 | 1.4354 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 957.00 | 799.25 | 1.1974 | 1.4194 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 414.82 | 903.00 | 799.25 | 1.1298 | 1.2754 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 625.00 | 414.82 | 551.00 | 799.25 | 0.6894 | 0.3499 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 567.00 | 799.25 | 0.7094 | 0.3914 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 711.00 | 799.25 | 0.8896 | 0.7674 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 625.00 | 414.82 | 306.00 | 799.25 | 0.3829 | -0.2750 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 766.00 | 799.25 | 0.9584 | 0.9122 |